In particular, we identified those miRNAs that are deregulated in LSCs independently from BCR-ABL kinase activity and therefore are likely to be involved in the BCR-ABL-independent resistance to TKI that characterizes CML LSCs. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.